Ipsen Group - Company & Market Research Reports

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
From
From
From
From
Osteoporosis - Pipeline Review, H2 2018 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 273 Pages
From
Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 251 Pages
From
From
Brain Hemorrhage - Pipeline Insight, 2018 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Pheochromocytoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 94 Pages
From
Pheochromocytoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 99 Pages
From
From
From
From
Loading Indicator
adroll